Medication info
Rizonel Plus Tablets (Risedronate Sodium 2.5 Hydrate, Colecalciferol Concentrate (Powder Form))

Rizonel Plus Tablets (Risedronate Sodium 2.5 Hydrate, Colecalciferol Concentrate (Powder Form))

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
IYOUN Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablets
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201605347 · Approved 2016.08.31 · Insurance code 658603390

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Elderly patients: No dosage adjustment is necessary in elderly patients (60 years of age and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. This drug must not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking this drug. Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need to take additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this drug provides a week's supply of vitamin D at 800 IU daily. If a patient forgets to take this drug on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Pediatrics: The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
IYOUN Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis that can occur in both postmenopausal women and men. Osteoporosis is a condition where the strength of bones weakens, increasing the risk of fractures, and this drug helps strengthen bones and reduce the risk of fractures. Therefore, it is an essential medication to maintain healthy bones and prevent problems related to osteoporosis.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Elderly patients: No dosage adjustment is necessary in elderly patients (60 years of age and older), because the bioavailability and pharmacokinetics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. This drug must not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking this drug. Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need to take additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this drug provides a week's supply of vitamin D at 800 IU daily. If a patient forgets to take this drug on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Pediatrics: The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication can irritate the gastrointestinal mucosa, which may cause symptoms such as esophagitis, esophageal ulcers, and esophageal erosion. If you experience symptoms such as difficulty swallowing, pain while swallowing, pain behind the breastbone, or heartburn during treatment, stop taking the medication immediately and consult a doctor. When taking this medication, it is important to take it with a sufficient amount of water (170–230 mL) and to remain upright for at least 30 minutes after taking it. It is crucial to take it at least 30 minutes before or after meals with an interval. Patients with esophageal dysmotility, severe kidney impairment, hypocalcemia, or lactose intolerance should not take this medication. The effectiveness of this drug may be reduced if taken with other medications that interfere with the absorption of calcium and vitamin D, so sufficient time intervals should be maintained between doses. Patients undergoing dental surgery or with oral diseases are at risk of jaw necrosis, so they should consult a doctor before dental treatment and pay special attention to oral hygiene. Use of this medication is not recommended during pregnancy or breastfeeding, and it is necessary to consult a doctor before use. In case of overdose, symptoms of hypocalcemia may occur, so caution is needed, and patients should inform medical personnel immediately if any abnormal symptoms arise. The elderly can generally use this medication safely, but it is advisable to consult a doctor if there are any specific health conditions. During treatment, it is important to consume sufficient calcium and vitamin D along with weight-bearing exercises, and it is advisable to avoid smoking and excessive alcohol consumption.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • hemorrhage
  • gastric ulcer
  • duodenitis
  • glossitis
  • nausea
Show 105 more
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal diseases
  • rectal diseases
  • dental diseases
  • petechiae
  • anemia
  • joint pain
  • joint disorders
  • myalgia
  • bone pain
  • bone disorders
  • leg cramps
  • bursitis
  • tendon disorders
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • lightheadedness
  • tension headache
  • sensory disturbances
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injuries due to accidents
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • indigestion
  • queasiness
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • arthritis
  • myalgia
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • bronchitis
  • low back pain
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • neck pain
  • weakness
  • hypertension
  • hyperlipidemia
  • uveitis
  • iritis
  • osteonecrosis of the jaw
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin reactions
  • liver dysfunction
  • jaundice
  • external ear canal osteonecrosis
  • loss of appetite
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial swelling
  • hair loss
  • abnormal olfactory sensation
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • polyuria
  • polydipsia
  • frailty
  • somnolence
  • atypical fractures

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication and ensure safe use.

Appearance and packaging

Appearance

Light orange oval film-coated tablets

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.